Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19179558 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.
Conditions: Metastatic Breast Cancer;   Neoplasms, Breast
Intervention: Drug: Investigational Cancer Drug

Indicates status has not been verified in more than two years